
BMGL P/E Ratio
P/E Ratio as of Jun 13, 2025: 36.58
Average33.15
Median39.01
Minimum10.78
Maximum64.27
36.58
Past Month+8.78 (31.58%)
The P/E ratio for BMGL is 36.58 as of Jun 13, 2025. This represents a increase of 95.93% compared to its 12-month average P/E ratio of 18.67. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Basel Medical Group Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Basel Medical Group Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Basel Medical Group Ltd to industry peers.
Basel Medical Group Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Basel Medical Group Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Basel Medical Group Ltd to industry peers.
BMGL P/E Ratio Insights
See Basel Medical Group Ltd’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in BMGL
Order type
Buy in
Order amount
Est. shares
0 shares
BMGL P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $3.92 | 41.44 |
May 1, 2025 | $4.07 | 43.02 |
Apr 1, 2025 | $5.00 | 52.85 |
Mar 3, 2025 | $4.20 | 44.40 |
Feb 24, 2025 | $4.00 | 42.28 |
BMGL End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | 36.58 | — |
FAQs About Basel Medical Group Ltd (BMGL) P/E ratio
The latest P/E ratio of BMGL is 36.58, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Basel Medical Group Ltd’s last 12-month average P/E ratio is 18.67, compared to its current P/E ratio of 36.58. This reflects a increase of 95.93%.
Basel Medical Group Ltd’s current P/E ratio of 36.58 is higher than its last 12-month average P/E of 18.67. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Basel Medical Group Ltd’s average P/E ratio over the last 3 years is 6.22. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Basel Medical Group Ltd’s average P/E ratio over the last 5 years is 3.73. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.